Behavioral effects of the β3 adrenoceptor agonist SR58611A: Is it the putative prototype of a new class of antidepressant/anxiolytic drugs?
- 14 November 2007
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 573 (1-3) , 139-147
- https://doi.org/10.1016/j.ejphar.2007.06.048
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- Anxiogenic-like effects of mCPP microinfusions into the amygdala (but not dorsal or ventral hippocampus) in mice exposed to elevated plus-mazeBehavioural Brain Research, 2007
- Stressors affect the response of male and female rats to clomipramine in a model of behavioral despair (forced swim test)European Journal of Pharmacology, 2005
- Anxiolytic profile of HG1, a 5-HT-moduline antagonist, in three mouse models of anxietyEuropean Neuropsychopharmacology, 2004
- Tryptophan depletion reverses the therapeutic effect of selective serotonin reuptake inhibitors in social anxiety disorderBiological Psychiatry, 2004
- Anxiogenic and depressive-like effects, but no cognitive deficits, after repeated moderate tryptophan depletion in the ratJournal of Psychopharmacology, 2002
- Serotonin and panicThe British Journal of Psychiatry, 1998
- A specific β3-adrenoceptor agonist induces increased pancreatic islet blood flow and insulin secretion in ratsEuropean Journal of Pharmacology, 1996
- In vitro inhibition of intestinal motility by phenylethanolaminotetralines: evidence of atypical β‐adrenoceptors in rat colonBritish Journal of Pharmacology, 1990
- Effect of serotonergic lesion on “anxious” behaviour measured in the elevated plus-maze test in the ratPsychopharmacology, 1990
- 5‐HYDROXYINDOLE METABOLISM IN RAT BRAIN. A STUDY OF INTERMEDIATE METABOLISM USING THE TECHNIQUE OF TRYPTOPHAN LOADING–I METHODSJournal of Neurochemistry, 1965